Cardiovascular Disease Risk in Patients with Rheumatic Diseases

• Autores: Rachel H. Mackey, Lewis H. Kuller, Larry W. Moreland
• Localización: Clinics in geriatric medicine, ISSN 0749-0690, Vol. 33, Nº. 1, 2017, págs. 105-117
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • Evidence suggests the greater than 1.5 increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA) is related to an accelerated burden of subclinical atherosclerosis that develops before the diagnosis of RA. Dyslipidemia in RA is better quantified by lipoproteins and apolipoproteins than cholesterol levels. Current risk factors likely underestimate CVD risk partly by underestimating prior risk factor levels. To reduce CVD risk in RA, control disease activity and aggressively treat CVD risk factors. Some of the two-fold higher risk of heart failure and total mortality in RA may be due to myocardial disease caused by inflammation.